GLP-1 persistence: What semaglutide data reveals about patient behavior
As the new year begins, many patients refocus on weight management and long-term health goals. At...
Topic
Marketplace
Improving influenza decision making with multimodal vaccination and lab data
Early signals indicate continued declines in influenza vaccination uptake and shifts in the...
Insights from IMPACCT 2025: advancing real-world evidence
Identifying the gaps in today’s real-world data The 2025 IMPACCT Real-World Evidence Summit brought...
Back to breakthrough data: HealthVerity Marketplace for healthcare data
Recently, HealthVerity COO and co-founder Andrew Goldberg spoke at a timely webinar: Back to...
Real-world evidence on cenobamate monotherapy in epilepsy
Why real-world data matters in epilepsy research Epilepsy affects millions of adults in the United...
The rise of conversational AI in healthcare using EHR data
AI agents are quickly becoming part of the clinical conversation. Since the release of large...
Measuring cost savings of virtual PT with HealthVerity Marketplace closed claims
Recently, Omada Health and HealthVerity announced a press release highlighting their collaboration...
GLP-1 trends 2025: real-world data, patient outcomes & future therapies
Few areas of medicine have captured public interest over the past two years quite like...
Disparities in OUD treatment: Buprenorphine vs. naltrexone
Understanding disparities in opioid use disorder (OUD) treatment Pharmaceutical companies committed...
Gilead uses HealthVerity data to find liver-protective treatment
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those...